Company:  ADVANCED CELL TECHNOLOGY, ... (ACTC)
Form Type:  8-K
Filing Date:  1/17/2013 
CIK:  0001140098 
Address:  33 LOCKE DRIVE 
City, State, Zip:  MARLBOROUGH, Massachusetts 01752 
Telephone:  508-756-1212 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.06  
Change: 
0.001 (1.72%)  
Trade Time: 
03:59 PM EST  
Market Cap: 
$163.84M
Description of Business
Advanced Cell Technology, Inc., a Delaware corporation (the �Company�, �ACT�, �we�, �us�, or �our�) is a biotechnology company, engaged in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. We are actively conducting clinical trials for treating dry age-related macular degeneration and Stargardt�s macular degeneration, in addition to several clinical and preclinical programs for other ocular therapies. We also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. Our intellectual property portfolio includes pluripotent human embryonic stem cell, or hESC; induced pluripotent stem cell, or iPSC, platforms; and other cell therapy research programs. Our corporate headquarters and principle laboratory and manufacturing facilities are located in Marlborough, Massachusetts.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into a Material Definitive Agreement.
    SECTION 2 FINANCIAL INFORMATION
      Item 2.03. Creation of a Direct Financial Obligation or an ...
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.02. Unregistered Sales of Equity Securities.
    SECTION 8 OTHER EVENTS
      Item 8.01. Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 10.4
  EXHIBIT 10.5
  EXHIBIT 99.1
BROKERAGE PARTNERS